These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21544508)

  • 41. Management of osteoporosis in geriatric populations.
    Schneider DL
    Curr Osteoporos Rep; 2008 Sep; 6(3):100-7. PubMed ID: 18752771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH
    Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
    Ringe JD; Farahmand P; Schacht E; Rozehnal A
    Rheumatol Int; 2007 Mar; 27(5):425-34. PubMed ID: 17216477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of osteoporosis in patients hospitalized for hip fractures.
    Ip TP; Leung J; Kung AW
    Osteoporos Int; 2010 Dec; 21(Suppl 4):S605-14. PubMed ID: 21058000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives.
    Lin X; Xiong D; Peng YQ; Sheng ZF; Wu XY; Wu XP; Wu F; Yuan LQ; Liao EY
    Clin Interv Aging; 2015; 10():1017-33. PubMed ID: 26150706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children.
    Galindo-Zavala R; Bou-Torrent R; Magallares-López B; Mir-Perelló C; Palmou-Fontana N; Sevilla-Pérez B; Medrano-San Ildefonso M; González-Fernández MI; Román-Pascual A; Alcañiz-Rodríguez P; Nieto-Gonzalez JC; López-Corbeto M; Graña-Gil J
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):20. PubMed ID: 32093703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postmenopausal osteoporosis: fracture risk and prevention.
    Kaunitz AM; McClung MR; Feldman RG; Wysocki S
    J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.
    Ferrari S; Reginster JY; Brandi ML; Kanis JA; Devogelaer JP; Kaufman JM; Féron JM; Kurth A; Rizzoli R
    Arch Osteoporos; 2016 Dec; 11(1):37. PubMed ID: 27800591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Mawatari T; Muraoka R; Iwamoto Y
    Osteoporos Int; 2017 Apr; 28(4):1279-1286. PubMed ID: 27900428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.
    Jennings LA; Auerbach AD; Maselli J; Pekow PS; Lindenauer PK; Lee SJ
    J Am Geriatr Soc; 2010 Apr; 58(4):650-7. PubMed ID: 20398147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists].
    Heberlein I; Demary W; Bloching H; Braun J; Buttgereit F; Dreher R; Kuhn C; Lange U; Zink A; Zeidler H; Häntzschel H; Raspe H
    Z Rheumatol; 2011 Sep; 70(7):592-601. PubMed ID: 21755301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteoporosis in the Women's Health Initiative: Another Treatment Gap?
    Sattari M; Cauley JA; Garvan C; Johnson KC; LaMonte MJ; Li W; Limacher M; Manini T; Sarto GE; Sullivan SD; Wactawski-Wende J; Beyth RJ
    Am J Med; 2017 Aug; 130(8):937-948. PubMed ID: 28366425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The patient's page. Bone health facts.
    McKinney J
    South Med J; 2005 Oct; 98(10):1058. PubMed ID: 16295830
    [No Abstract]   [Full Text] [Related]  

  • 56. Fractures related to bone fragility: prevention First-choice treatments.
    Prescrire Int; 2017 Apr; 26(181):103-106. PubMed ID: 30730663
    [No Abstract]   [Full Text] [Related]  

  • 57. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
    Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
    Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rates of osteoporosis screening and treatment following vertebral fracture.
    Barton DW; Behrend CJ; Carmouche JJ
    Spine J; 2019 Mar; 19(3):411-417. PubMed ID: 30142455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinician's Guide to Prevention and Treatment of Osteoporosis.
    Cosman F; de Beur SJ; LeBoff MS; Lewiecki EM; Tanner B; Randall S; Lindsay R;
    Osteoporos Int; 2014 Oct; 25(10):2359-81. PubMed ID: 25182228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Osteoporosis in the man: broad indication for strontium ranelate].
    MMW Fortschr Med; 2012 Nov; 154(21):86-7. PubMed ID: 23270063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.